| Literature DB >> 29716847 |
Michael M Engelgau1, K M Venkat Narayan2, Majid Ezzati3, Luis A Salicrup4, Deshiree Belis5, Laudan Y Aron6, Robert Beaglehole7, Alain Beaudet8, Peter A Briss9, David A Chambers10, Marion Devaux11, Kevin Fiscella12, Michael Gottlieb13, Unto Hakkinen14, Rain Henderson15, Anselm J Hennis16, Judith S Hochman17, Stephen Jan18, Walter J Koroshetz19, Johan P Mackenbach20, M G Marmot21, Pekka Martikainen22, Mark McClellan23, David Meyers24, Polly E Parsons25, Clas Rehnberg26, Darshak Sanghavi27, Stephen Sidney28, Anna Maria Siega-Riz29, Sharon Straus30, Steven H Woolf31, Stephanie Constant32, Tony L Creazzo32, Janet M de Jesus5, Nara Gavini33, Norma B Lerner34, Helena O Mishoe5, Cheryl Nelson35, Emmanuel Peprah5, Antonello Punturieri36, Uchechukwu Sampson5, Rachael L Tracy37, George A Mensah5.
Abstract
Four decades ago, U.S. life expectancy was within the same range as other high-income peer countries. However, during the past decades, the United States has fared worse in many key health domains resulting in shorter life expectancy and poorer health-a health disadvantage. The National Heart, Lung, and Blood Institute convened a panel of national and international health experts and stakeholders for a Think Tank meeting to explore the U.S. health disadvantage and to seek specific recommendations for implementation research opportunities for heart, lung, blood, and sleep disorders. Recommendations for National Heart, Lung, and Blood Institute consideration were made in several areas including understanding the drivers of the disadvantage, identifying potential solutions, creating strategic partnerships with common goals, and finally enhancing and fostering a research workforce for implementation research. Key recommendations included exploring why the United States is doing better for health indicators in a few areas compared with peer countries; targeting populations across the entire socioeconomic spectrum with interventions at all levels in order to prevent missing a substantial proportion of the disadvantage; assuring partnership have high-level goals that can create systemic change through collective impact; and finally, increasing opportunities for implementation research training to meet the current needs. Connecting with the research community at large and building on ongoing research efforts will be an important strategy. Broad partnerships and collaboration across the social, political, economic, and private sectors and all civil society will be critical-not only for implementation research but also for implementing the findings to have the desired population impact. Developing the relevant knowledge to tackle the U.S. health disadvantage is the necessary first step to improve U.S. health outcomes. Published by Elsevier B.V.Entities:
Mesh:
Year: 2018 PMID: 29716847 PMCID: PMC6504971 DOI: 10.1016/j.gheart.2018.03.003
Source DB: PubMed Journal: Glob Heart